Research ArticleArticle
The Respective Roles of CYP3A4 and CYP2D6 in the Metabolism of Pimozide to Established and Novel Metabolites
Brian D. Chapron, Jean C. Dinh, Paul C. Toren, Andrea Gaedigk and J. Steven Leeder
Drug Metabolism and Disposition November 2020, 48 (11) 1113-1120; DOI: https://doi.org/10.1124/dmd.120.000188
Brian D. Chapron
Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children’s Mercy Kansas City, Kansas City, Missouri
Jean C. Dinh
Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children’s Mercy Kansas City, Kansas City, Missouri
Paul C. Toren
Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children’s Mercy Kansas City, Kansas City, Missouri
Andrea Gaedigk
Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children’s Mercy Kansas City, Kansas City, Missouri
J. Steven Leeder
Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Department of Pediatrics, Children’s Mercy Kansas City, Kansas City, Missouri
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Roles of CYP2D6 and CYP3A4 in Pimozide Metabolism
Brian D. Chapron, Jean C. Dinh, Paul C. Toren, Andrea Gaedigk and J. Steven Leeder
Drug Metabolism and Disposition November 1, 2020, 48 (11) 1113-1120; DOI: https://doi.org/10.1124/dmd.120.000188
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement